These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 19924111)

  • 1. Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.
    Horstmann S; Lucae S; Menke A; Hennings JM; Ising M; Roeske D; Müller-Myhsok B; Holsboer F; Binder EB
    Neuropsychopharmacology; 2010 Feb; 35(3):727-40. PubMed ID: 19924111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.
    Paddock S; Laje G; Charney D; Rush AJ; Wilson AF; Sorant AJ; Lipsky R; Wisniewski SR; Manji H; McMahon FJ
    Am J Psychiatry; 2007 Aug; 164(8):1181-8. PubMed ID: 17671280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression.
    Ising M; Maccarrone G; Brückl T; Scheuer S; Hennings J; Holsboer F; Turck CW; Uhr M; Lucae S
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics studies in STAR*D: strengths, limitations, and results.
    Laje G; Perlis RH; Rush AJ; McMahon FJ
    Psychiatr Serv; 2009 Nov; 60(11):1446-57. PubMed ID: 19880459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA sequence variants of the FKBP5 gene are associated with unipolar depression.
    Zobel A; Schuhmacher A; Jessen F; Höfels S; von Widdern O; Metten M; Pfeiffer U; Hanses C; Becker T; Rietschel M; Scheef L; Block W; Schild HH; Maier W; Schwab SG
    Int J Neuropsychopharmacol; 2010 Jun; 13(5):649-60. PubMed ID: 20047716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive Disorders.
    Poweleit EA; Aldrich SL; Martin LJ; Hahn D; Strawn JR; Ramsey LB
    J Child Adolesc Psychopharmacol; 2019 Jun; 29(5):348-361. PubMed ID: 31066578
    [No Abstract]   [Full Text] [Related]  

  • 7. The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression.
    Stamm TJ; Rampp C; Wiethoff K; Stingl J; Mössner R; O Malley G; Ricken R; Seemüller F; Keck M; Fisher R; Gaebel W; Maier W; Möller HJ; Bauer M; Adli M
    J Psychopharmacol; 2016 Jan; 30(1):40-7. PubMed ID: 26645208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.
    Ising M; Lucae S; Binder EB; Bettecken T; Uhr M; Ripke S; Kohli MA; Hennings JM; Horstmann S; Kloiber S; Menke A; Bondy B; Rupprecht R; Domschke K; Baune BT; Arolt V; Rush AJ; Holsboer F; Müller-Myhsok B
    Arch Gen Psychiatry; 2009 Sep; 66(9):966-975. PubMed ID: 19736353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort.
    Lekman M; Laje G; Charney D; Rush AJ; Wilson AF; Sorant AJ; Lipsky R; Wisniewski SR; Manji H; McMahon FJ; Paddock S
    Biol Psychiatry; 2008 Jun; 63(12):1103-10. PubMed ID: 18191112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
    McMahon FJ; Buervenich S; Charney D; Lipsky R; Rush AJ; Wilson AF; Sorant AJM; Papanicolaou GJ; Laje G; Fava M; Trivedi MH; Wisniewski SR; Manji H
    Am J Hum Genet; 2006 May; 78(5):804-814. PubMed ID: 16642436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics in major depression: a comprehensive meta-analysis.
    Niitsu T; Fabbri C; Bentini F; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():183-94. PubMed ID: 23733030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTR2A gene variation is involved in antidepressant treatment response.
    Lucae S; Ising M; Horstmann S; Baune BT; Arolt V; Müller-Myhsok B; Holsboer F; Domschke K
    Eur Neuropsychopharmacol; 2010 Jan; 20(1):65-8. PubMed ID: 19758789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatization in major depression--clinical features and genetic associations.
    Klengel T; Heck A; Pfister H; Brückl T; Hennings JM; Menke A; Czamara D; Müller-Myhsok B; Ising M
    Acta Psychiatr Scand; 2011 Oct; 124(4):317-28. PubMed ID: 21838737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
    Laje G; Cannon DM; Allen AS; Klaver JM; Peck SA; Liu X; Manji HK; Drevets WC; McMahon FJ
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):715-24. PubMed ID: 20047709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response.
    Peters EJ; Slager SL; Jenkins GD; Reinalda MS; Garriock HA; Shyn SI; Kraft JB; McGrath PJ; Hamilton SP
    Pharmacogenet Genomics; 2009 Jan; 19(1):1-10. PubMed ID: 19077664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
    Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
    Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between FKBP5 polymorphisms and depression symptoms among kidney transplant recipients.
    Shinozaki G; Jowsey S; Amer H; Biernacka J; Colby C; Walker D; Black J; Rundell J; Stegall M; Mrazek DA
    Depress Anxiety; 2011 Dec; 28(12):1111-8. PubMed ID: 22134958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of 34 candidate genes in bupropion and placebo remission.
    Tiwari AK; Zai CC; Sajeev G; Arenovich T; Müller DJ; Kennedy JL
    Int J Neuropsychopharmacol; 2013 May; 16(4):771-81. PubMed ID: 22947179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FKBP5 polymorphisms and antidepressant response in geriatric depression.
    Sarginson JE; Lazzeroni LC; Ryan HS; Schatzberg AF; Murphy GM
    Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):554-560. PubMed ID: 19676097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.
    Perlis RH; Moorjani P; Fagerness J; Purcell S; Trivedi MH; Fava M; Rush AJ; Smoller JW
    Neuropsychopharmacology; 2008 Nov; 33(12):2810-9. PubMed ID: 18288090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.